These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26019477)

  • 1. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis.
    Song Y; Shi YH; He C; Liu CQ; Wang JS; Zhao YJ; Guo YM; Wu RJ; Feng XY; Liu ZJ
    World J Gastroenterol; 2015 May; 21(19):6082-7. PubMed ID: 26019477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitis.
    Laresche C; Locatelli F; Biver-Dalle C; Nachury M; Heyd B; Koch S; Aubin F
    Cutis; 2017 Jan; 99(1):E20-E22. PubMed ID: 28207014
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes zoster infection followed by Henoch-Schönlein purpura in a girl receiving infliximab for ulcerative colitis.
    Nobile S; Catassi C; Felici L
    J Clin Rheumatol; 2009 Mar; 15(2):101. PubMed ID: 19265360
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous vasculitis in ulcerative colitis mimicking Henoch-Schönlein purpura.
    de Oliveira GT; Martins SS; Deboni M; Picciarelli P; Campos LM; Jesus AA; Koda YK; Silva CA
    J Crohns Colitis; 2013 Mar; 7(2):e69-73. PubMed ID: 22626504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA vasculitis in a patient with ulcerative colitis under infliximab: drug-induced or genetic?
    Urushikubo J; Yanai S; Nakamura S; Toya Y; Asakura K; Gonai T; Eizuka M; Uesugi N; Sugai T; Matsumoto T
    Clin J Gastroenterol; 2021 Feb; 14(1):198-203. PubMed ID: 33141395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting.
    Checkley LA; Kristofek L; Kile S; Bolgar W
    Dig Dis Sci; 2019 Mar; 64(3):855-862. PubMed ID: 30311152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Henoch-Schönlein purpura after etanercept therapy for psoriasis.
    Lee A; Kasama R; Evangelisto A; Elfenbein B; Falasca G
    J Clin Rheumatol; 2006 Oct; 12(5):249-51. PubMed ID: 17023811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea.
    Park SH; Kim YH; Lee JH; Kwon HJ; Lee SH; Park DI; Kim HK; Cheon JH; Im JP; Kim YS; Lee SY; Lee SJ
    Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():35-44. PubMed ID: 26395533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Henoch-Schönlein purpura complicating adalimumab therapy.
    Marques I; Lagos A; Reis J; Pinto A; Neves B
    J Crohns Colitis; 2012 Aug; 6(7):796-9. PubMed ID: 22445079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocytoclastic Vasculitis Mimicking Henoch-Schönlein Purpura Preceding Onset of Ulcerative Colitis in a Child.
    Kapur SV; Oswal JS
    Indian J Pediatr; 2021 May; 88(5):507-508. PubMed ID: 33591441
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J; Detlie TE; Vatn S; Ricanek P
    Expert Rev Gastroenterol Hepatol; 2015; 9 Suppl 1():45-52. PubMed ID: 26395534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter investigation of diagnosis and treatment of Henoch-Schonlein purpura nephritis in childhood].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Disease
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):881-7. PubMed ID: 24495756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
    Cortes X; Borrás-Blasco J; Fernendez S; Moreno M; Rodríguez J; Molés JR; Casterá E
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):125-8. PubMed ID: 26754306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Henoch-Schönlein purpura in children.
    Trnka P
    J Paediatr Child Health; 2013 Dec; 49(12):995-1003. PubMed ID: 24134307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy?
    Pinheiro RR; Lencastre A
    Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732
    [No Abstract]   [Full Text] [Related]  

  • 18. Nephrotic syndrome after infliximab treatment in a patient with ulcerative colitis.
    Dumitrescu G; Dahan K; Treton X; Corcos O; Bouhnik Y; Stefanescu C
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):249-51. PubMed ID: 26114187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of disease may predict response to infliximab in pediatric ulcerative colitis.
    Mir SA; Nagy-Szakal D; Smith EO; Gilger MA; Kellermayer R
    J Clin Gastroenterol; 2014 Mar; 48(3):248-52. PubMed ID: 24129407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small vessel vasculitis of the skin.
    Micheletti RG; Werth VP
    Rheum Dis Clin North Am; 2015; 41(1):21-32, vii. PubMed ID: 25399937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.